Advanced genomics and clinical phenotypes in psoriatic arthritis by Vecellio, M, Rodolfi, S, Selmi, C

Susceptibility to ankylosing spondylitis is influenced independently by two closely adjacent RUNX3 single nucleotide polymorphisms that show strong functional effect in different c... by Vecellio, M, Roberts, A, Wordsworth, B

Quantifying the genetic risk for the development of axial spondyloarthropathy: could this become a diagnostic tool? by Wordsworth, BP, Cohen, CJ, Vecellio, M

Reply to Reeves et al.: No evidence for rare ERAP1 haplotypes and haplotype combinations in ankylosing spondylitis by Wordsworth, B, Vecellio, M, Roberts, A

The role of epigenetics and immunological imbalance in the etiopathogenesis of psoriasis and psoriatic arthritis by Frischknecht, L, Vecellio, M, Selmi, C

Editorial: Role of the IL-23/IL-17 pathway in chronic immune-mediated inflammatory diseases: mechanisms and targeted therapies by Bianchi, E, Vecellio, M, Rogge, L

Perspectives on the genetic associations of ankylosing spondylitis by Wordsworth, BP, Cohen, CJ, Davidson, C, Vecellio, M

THU0364 Rare ERAP1 allotype combinations do not explain the ERAP1 association with ankylosing spondylitis by Appleton, LH, Roberts, AR, Vecellio, M, Wordsworth, BP

FROM SNPs TO FUNCTION: TRANSCRIPTIONAL REGULATION OF RUNX3 IN ANKYLOSING SPONDYLITIS by Vecellio, M, Roberts, A, Cohen, C, Bowness, P, Wordsworth, B

ANKYLOSING SPONDYLITIS-ASSOCIATED SNPS AT THE IL23R-IL12RB2 INTERGENIC REGION ARE FUNCTIONALLY IMPORTANT by Roberts, A, Cohen, C, Vecellio, M, Bowness, P, Wordsworth, B

RUNX3 and T-Bet in immunopathogenesis of ankylosing spondylitis—novel targets for therapy? by Vecellio, M, Cohen, CJ, Roberts, AR, Wordsworth, PB, Kenna, TJ

OP0231 Differential transcription factor binding could explain the genetic association of ankylosing spondylitis with polymorphisms in the IL23R-IL12RB2 intergenic region by Roberts, AR, Vecellio, M, Chen, L, Cohen, CJ, Wordsworth, BP

Investigation of a possible extended risk haplotype in the IL23R region associated with ankylosing spondylitis by Roberts, A, Vecellio, M, Cortes, A, Knight, J, Cohen, C, Wordsworth, B

Disruption of c-MYC binding and chromosomal looping involving genetic variants associated with ankylosing spondylitis upstream of the RUNX3 promoter by Cohen, CJ, Davidson, C, Selmi, C, Bowness, P, Knight, JC, Wordsworth, BP, Vecellio, M

The genetic association of RUNX3 with ankylosing spondylitis can be explained by allele-specific effects on IRF4 recruitment that alter gene expression by Vecellio, M, Roberts, AR, Cohen, CJ, Cortes, A, Knight, JC, Bowness, P, Wordsworth, BP

The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in... by Watts, L, Karaderi, T, Roberts, A, Appleton, L, Wordsworth, T, Cohen, C, Wordsworth, P, Vecellio, M

The association of a common functional polymorphism in the tumour necrosis factor receptor 1 gene (TNFRSF1A) and disease severity in ankylosing spondylitis by Watts, L, Karaderi, T, Roberts, A, Vecellio, M, Appleton, L, Judge, A, Wordsworth, T, Cohen, C, Wordsworth, B

ERAP1 association with ankylosing spondylitis is attributable to common genotypes rather than rare haplotype combinations by Roberts, A, Appleton, L, Cortes, A, Vecellio, M, Lau, J, Watts, L, Brown, M, Wordsworth, B

An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation by Roberts, AR, Vecellio, M, Chen, L, Ridley, A, Cortes, A, Knight, JC, Bowness, P, Cohen, CJ, Wordsworth, BP

Evidence for a second ankylosing spondylitis-associated RUNX3 regulatory polymorphism by Vecellio, M, Cortes, A, Roberts, A, Ellis, J, Cohen, C, Knight, J, Brown, M, Bowness, P, Wordsworth, B